
HealthCare Ventures is the famous VC, which was founded in 1985. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the Cambridge.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the HealthCare Ventures, startups are often financed by MPM Capital, Amgen Ventures, Morgenthaler Ventures. The meaningful sponsors for the fund in investment in the same round are Rho Ventures, Novartis Venture Fund, New Enterprise Associates. In the next rounds fund is usually obtained by Oxford Bioscience Partners, MPM Capital, Morgenthaler Ventures.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Genetics, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Senseonics, Catalyst Biosciences, TetraLogic Pharmaceuticals. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 deals per year. The real fund results show that this VC is 3 percentage points more often commits exit comparing to other companies. Comparing to the other companies, this HealthCare Ventures performs on 1 percentage points more the average number of lead investments. The top activity for fund was in 2011. The higher amount of exits for fund were in 2016. When the investment is from HealthCare Ventures the average startup value is 10-50 millions dollars.
The current fund was established by Harold Werner. We also calculated 6 valuable employees in our database.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Proteostasis Therapeutics | $37M | 08 Sep 2015 | Cambridge, Massachusetts, United States | ||
Galleon Pharmaceuticals | $10M | 11 Jun 2015 | Horsham Township, Pennsylvania, United States | ||
Vaxxas | $25M | 10 Feb 2015 | New South Wales | ||
Colorescience | $15M | 10 Sep 2014 | Carlsbad, California, United States | ||
Pathogenetix | $10M | 30 Oct 2013 | Woburn, Massachusetts, United States | ||
Theraclone Sciences | $8M | 25 Mar 2013 | Seattle, Washington, United States | ||
Cleveland HeartLab | $14M | 31 Oct 2012 | Cleveland, Ohio, United States | ||
01 Jan 2012 | Cambridge, Massachusetts, United States | ||||
Mosaic Biosciences | $1M | 08 Nov 2011 | Boulder, Colorado, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Proteostasis Therapeutics | $37M | 08 Sep 2015 | Cambridge, Massachusetts, United States | ||
Galleon Pharmaceuticals | $10M | 11 Jun 2015 | Horsham Township, Pennsylvania, United States | ||
Vaxxas | $25M | 10 Feb 2015 | New South Wales | ||
Colorescience | $15M | 10 Sep 2014 | Carlsbad, California, United States | ||
Pathogenetix | $10M | 30 Oct 2013 | Woburn, Massachusetts, United States | ||
Theraclone Sciences | $8M | 25 Mar 2013 | Seattle, Washington, United States | ||
Cleveland HeartLab | $14M | 31 Oct 2012 | Cleveland, Ohio, United States | ||
01 Jan 2012 | Cambridge, Massachusetts, United States | ||||
Mosaic Biosciences | $1M | 08 Nov 2011 | Boulder, Colorado, United States |